Literature DB >> 35213427

Comparing Gold-standard Copayment and Coinsurance Values From Claims Processing Engines to Values Derived From Behavioral Health Claims Databases.

Sarah A Friedman1, Haiyong Xu2, Francisca Azocar3, Susan L Ettner2,4.   

Abstract

BACKGROUND: While researchers use patient expenditures in claims data to estimate insurance benefit features, little evidence exists to indicate whether the resulting measures are accurate.
OBJECTIVE: To develop and test an algorithm for deriving copayment and coinsurance values from behavioral health claims data.
SUBJECTS: Employer-sponsored insurance plans from 2011 to 2013 for a national managed behavioral health organization (MBHO). MEASURES: Twelve benefit features, distinguishing between carve-in and carve-out, in-network and out-of-network, inpatient and outpatient, and copayment and coinsurance, were created. Measures drew from claims (claims-derived measures), and benefit feature data from a claims processing engine database (true measures). STUDY
DESIGN: We calculate sensitivity and specificity of the claims-derived measures' ability to accurately determine if a benefit feature was required and for plan-years requiring the benefit feature, the accuracy of the claims-derived measures. Accuracy rates using the minimum, 25th, 50th, 75th, and maximum claims value for a plan-year were compared. PRINCIPAL
FINDINGS: Sensitivity (82% or higher for all but 3 benefit features) and specificity (95% or higher for all but 2 benefit features) were relatively high. Accuracy rates were highest using the 75th or maximum claims value, depending on the benefit feature, and ranged from 69% to 99% for all benefit features except for out-of-network inpatient coinsurance.
CONCLUSIONS: For most plan-years, claims-derived measures correctly identify required specialty mental health copayments and coinsurance, although the claims-derived measures' accuracy varies across benefit design features. This information should be considered when creating claims-derived benefit features to use for policy analysis.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35213427      PMCID: PMC8917070          DOI: 10.1097/MLR.0000000000001698

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  22 in total

1.  Impact of statin copayments on adherence and medical care utilization and expenditures.

Authors:  Teresa B Gibson; Tami L Mark; Kirsten Axelsen; Onur Baser; Dale A Rublee; Kimberly A McGuigan
Journal:  Am J Manag Care       Date:  2006-12       Impact factor: 2.229

2.  Evaluating agreement with a gold standard in method comparison studies.

Authors:  R T St Laurent
Journal:  Biometrics       Date:  1998-06       Impact factor: 2.571

3.  Healthcare Coinsurance Elasticity Coefficient Estimation Using Monthly Cross-sectional, Time-series Claims Data.

Authors:  John F Scoggins; Daniel A Weinberg
Journal:  Health Econ       Date:  2016-03-30       Impact factor: 3.046

4.  The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Mental Health Financial Requirements among Commercial "Carve-In" Plans.

Authors:  Sarah A Friedman; Amber G Thalmayer; Francisca Azocar; Haiyong Xu; Jessica M Harwood; Michael K Ong; Laura Lambert Johnson; Susan L Ettner
Journal:  Health Serv Res       Date:  2016-12-12       Impact factor: 3.402

5.  Leveraging benefit design for better diabetes self-management and A1C control.

Authors:  Abiy Agiro; Yiqiong Xie; Kevin Bowman; Andrea DeVries
Journal:  Am J Manag Care       Date:  2018-02-01       Impact factor: 2.229

6.  Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis.

Authors:  Pinar Karaca-Mandic; Geoffrey F Joyce; Dana P Goldman; Marianne Laouri
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

7.  Cost sharing and branded antidepressant initiation among patients treated with generics.

Authors:  Jason D Buxbaum; Michael E Chernew; Machaon Bonafede; Anna Vlahiotis; Deborah Walter; Lisa Mucha; A Mark Fendrick
Journal:  Am J Manag Care       Date:  2018-04       Impact factor: 2.229

8.  Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban.

Authors:  Alison A Galbraith; Vicki Fung; Lingling Li; Melissa G Butler; James D Nordin; John Hsu; David Smith; William M Vollmer; Tracy A Lieu; Stephen B Soumerai; Ann Chen Wu
Journal:  Health Serv Res       Date:  2016-11-20       Impact factor: 3.402

9.  The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance.

Authors:  Lydia E Pace; Stacie B Dusetzina; A Mark Fendrick; Nancy L Keating; Vanessa K Dalton
Journal:  Med Care       Date:  2013-11       Impact factor: 2.983

10.  Cost sharing for antiepileptic drugs: medication utilization and health plan costs.

Authors:  Nina R Joyce; Jesse Fishman; Sarah Green; David M Labiner; Imane Wild; David C Grabowski
Journal:  Am J Manag Care       Date:  2018-06-01       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.